Enhanced Percent Age of Leu M3+Dr+ and Leu M3+Cd25+ Cells in Newly Diagnosed Iddm Patients
作者： F. Nicoletti , U. Consoli , D. Calogero , A. M. Speciale , R. Di Marco
DOI: 10.3109/08916939109007651
关键词:
摘要: The percentage of Leu M3+DR+ and M3+CD25+ cells was determined by means immunofluorescence analysis in a group patients with insulin dependent diabetes mellitus (IDDM). Our results show that an increased these may occur the early stage disease. These data provide evidence for “phenotypical” activation M3+ at onset disease warrant future studies to evaluate potential role pathogenesis IDDM.
elsevier.com
informahealthcare.com参考文章(18)
S A Cannistra, F Herrmann, J D Griffin, D Blohm, A Lindemann, A Rambaldi, R H Mertelsmann, Functional consequences of monocyte IL-2 receptor expression. Induction of IL-1 beta secretion by IFN gamma and IL-2. Journal of Immunology. ,vol. 142, pp. 139- 143 ,(1989)
K. C. Herold, A. Huen, L. Gould, H. Traisman, A. H. Rubenstein, Alterations in lymphocyte subpopulations in type 1 (insulin-dependent) diabetes mellitus: exploration of possible mechanisms and relationships to autoimmune phenomena Diabetologia. ,vol. 27, pp. 102- 105 ,(1984) , 10.1007/BF00275660
J. Zielasek, R.A. Jackson, G.S. Eisenbarth, The potentially simple mathematics of type I diabetes. Clinical Immunology and Immunopathology. ,vol. 52, pp. 347- 365 ,(1989) , 10.1016/0090-1229(89)90150-5
F. Nicoletti, P.L. Meroni, W. Barcellini, P.Ø. Steinsväg, M. Di Mauro, M. Lunetta, M. Pagano, U. Consoli, C. Zanussi, Enhanced percentage of CD5+ B lymphocytes in newly diagnosed IDDM patients. Immunology Letters. ,vol. 23, pp. 211- 215 ,(1990) , 10.1016/0165-2478(90)90194-U
Klaus Bendtzen, Immune hormones (cytokines); pathogenic role in autoimmune rheumatic and endocrine diseases. Autoimmunity. ,vol. 2, pp. 177- 189 ,(1989) , 10.3109/08916938909019954
M.G. Roncarolo, M. Zoppo, R. Bacchetta, C. Gabiano, C. Sacchetti, F. Cerutti, P.A. Tovo, Interleukin-2 production and interleukin-2 receptor expression in children with newly diagnosed diabetes. Clinical Immunology and Immunopathology. ,vol. 49, pp. 53- 62 ,(1988) , 10.1016/0090-1229(88)90094-3
Ricardo Pujol–Borrell, Ian Todd, Mala Doshi, Gian Franco Bottazzo, Robert Sutton, Derek Gary, Gunther R. Adolf, Marc Feldmann, HLA class II induction in human islet cells by interferon-gamma plus tumour necrosis factor or lymphotoxin. Nature. ,vol. 326, pp. 304- 306 ,(1987) , 10.1038/326304A0
T. Yanagawa, T. Maruyama, I. Takei, Y. Asaba, T. Takahashi, K. Kataoka, S. Minoshima, N. Shimizu, T. Tadakuma, T. Ishii, Prevention of diabetes in NOD mice by silica treatment Journal of Autoimmunity. ,vol. 3, pp. 101- ,(1990) , 10.1016/0896-8411(90)90121-8
Shinichi Kakumu, Kentaro Yoshioka, Yasuhiko Tsutsumi, Takaji Wakita, Motohiro Arao, Production of tumor necrosis factor, interleukin 1, and interferon-γ by peripheral blood mononuclear cells from patients with primary biliary cirrhosis Clinical Immunology and Immunopathology. ,vol. 56, pp. 54- 65 ,(1990) , 10.1016/0090-1229(90)90169-Q
C. Pukel, H. Baquerizo, A. Rabinovitch, Destruction of Rat Islet Cell Monolayers by Cytokines: Synergistic Interactions of Interferon-γ, Tumor Necrosis Factor, Lymphotoxin, and Interleukin 1 Diabetes. ,vol. 37, pp. 133- 136 ,(1988) , 10.2337/DIAB.37.1.133